🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Gold Down Over Vaccine Hopes

Published 12/08/2020, 11:35 PM
Updated 12/08/2020, 11:36 PM
© Reuters.
XAU/USD
-
PFE
-
GC
-
GLD
-
BNTX
-

By Gina Lee

Investing.com – Gold was down on Wednesday morning in Asia, giving up gains made during Tuesday’s Asia session.

Gold futures were down 0.62% at $1,863.35 by 12:33 AM ET (4:33 AM GMT), but remained above the $1,800 mark. The dollar was also on a downward trend on Wednesday.

Investors continue to look to progress on a fresh $916 billion COVID-19 relief measures package presented by U.S. Treasury Secretary Steven Mnuchin to House of Representatives Speaker Nancy Pelosi. The price tag for Mnuchin’s proposed package, which he announced via Twitter on Tuesday, is slightly higher than that for a $908 billion package proposed by a bipartisan group of lawmakers during the previous week.

Senate Majority Leader Mitch McConnell also indicated his willingness to set aside some issues preventing passing the measures, viewed as a strategic retreat aimed at striking a deal.

With only two days left until a Dec. 11 deadline to avoid a government shutdown, the latest developments increased hopes that Republicans and Democrats will reach a consensus ahead of the deadline, even as Democrats oppose McConnell’s insistence on protecting employers from lawsuits. McConnell for his part criticized Democrats’ demands for assistance to state and local authorities, which he views as a bailout.

Across the Atlantic, Brexit trade deal talks between the U.K. and the European Union are also working to strike a deal before the end-of-year deadline.

The European Central Bank (ECB) and the Federal Reserve are also due to hand down their final policy decisions for 2020 on Thursday.

The U.S. Food and Drug Administration (FDA) will also convene to discuss BNT162b2, the COVID-19 vaccine co-developed by Pfizer (NYSE:PFE) and BioNTech SE (F:22UAy), on Thursday. Should the FDA grant emergency use authorization during its meeting, distribution could begin within 24 hours, according to Health & Human Services Secretary Alex Azar.

The U.K. has already inoculated its first patients with BNT162b2 after the U.K.’s Medicines & Healthcare Products Regulatory Agency granted a temporary authorization for emergency use during the previous week.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.